Table 1 |
|||
| Characteristics of study patients | |||
| Aspirin group | Non-Aspirin group | p value | |
| Number of patients | 145 | 348 | |
| Age | |||
| Mean (SE) | 72.1 (0.7) | 62.2 (0.7) | p<0.05 |
| Gender | |||
| Male | 83 (57.2%) | 191 (54.9%) | NS, p=0.63 |
| Concomitant NSAID use | 4 (2.8%) | 12 (3.5%) | NS, p=0.68 |
| Concomitant dipyridamole use | 2 (1.4%) | 3 (0.9%) | NS, p=0.64 |
| Polyp Data | |||
| Total number of polypectomies | 450 | 1052 | |
| Range of number of polyps removed per Patient | 1-30 | 1-26 | |
| Number of polypectomies per patient (SE) | 3.1 (0.3) | 3.1 (0.5) | NS, p=0.79 |
| Range of the size of polyp removed | 2-40 mm | 2-60mm | |
| Average size of largest polyp per patient (SE) | 9.6 (0.7) mm | 9.2 (0.5) mm | NS, p=0.59 |
| Polypectomy technique | |||
| Cold biopsy | 35 (24.1%) | 90 (25.9%) | NS, p=0.69 |
| Hot biopsy | 18 (12.4%) | 51 (14.7%) | NS, p=0.50 |
| Snare (blended current) | 92 (63.4%) | 207 (59.5%) | NS, p=0.43 |
| Number of patients presented with post-polypectomy bleed | 8 (5.5%) | 3 (0.8%) | p<0.05 |
Pan et al. BMC Gastroenterology 2012 12:138 doi:10.1186/1471-230X-12-138
